Immuneering reports Q1 2026 financial results and clinical updates
Go back to Immuneering reports Q1 2026 financial results and clinical updates| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 5.33 +0.30 (5.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.03 | 52 Week High | $0.04 | |||
| Open | $5.18 | 52 Week Low | $0.00 | |||
| Day High | $5.37 | P/E | N/A | |||
| Day Low | $5.14 | EPS | $-0.09 | |||
| Volume | 751,050 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 37.47 +0.89 (2.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.58 | 52 Week High | $66.55 | |||
| Open | $37.00 | 52 Week Low | $37.82 | |||
| Day High | $37.83 | P/E | N/A | |||
| Day Low | $36.60 | EPS | $0.00 | |||
| Volume | 7,975,791 | |||||
